CVS Health ROE 2010-2024 | CVS
Current and historical return on equity (ROE) values for CVS Health (CVS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CVS Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $4.61B | $75.73B | 6.15% |
| 2024-09-30 | $5.02B | $75.11B | 6.67% |
| 2024-06-30 | $7.19B | $75.11B | 9.57% |
| 2024-03-31 | $7.32B | $74.15B | 9.82% |
| 2023-12-31 | $8.34B | $76.64B | 11.29% |
| 2023-09-30 | $8.63B | $74.51B | 11.87% |
| 2023-06-30 | $2.97B | $73.00B | 4.13% |
| 2023-03-31 | $4.09B | $71.58B | 5.65% |
| 2022-12-31 | $4.31B | $71.77B | 5.90% |
| 2022-09-30 | $3.37B | $71.01B | 4.56% |
| 2022-06-30 | $8.38B | $75.51B | 11.18% |
| 2022-03-31 | $8.13B | $74.14B | 10.93% |
| 2021-12-31 | $8.00B | $75.38B | 10.86% |
| 2021-09-30 | $7.58B | $74.62B | 10.49% |
| 2021-06-30 | $7.20B | $73.57B | 10.16% |
| 2021-03-31 | $7.40B | $71.16B | 10.63% |
| 2020-12-31 | $7.18B | $69.70B | 10.53% |
| 2020-09-30 | $7.95B | $69.11B | 11.91% |
| 2020-06-30 | $8.26B | $68.36B | 12.66% |
| 2020-03-31 | $7.22B | $65.47B | 11.36% |
| 2019-12-31 | $6.63B | $64.17B | 10.67% |
| 2019-09-30 | $4.47B | $62.93B | 7.35% |
| 2019-06-30 | $4.33B | $61.60B | 7.99% |
| 2019-03-31 | $-0.17B | $60.01B | -0.36% |
| 2018-12-31 | $-0.59B | $58.54B | -1.40% |
| 2018-09-30 | $3.11B | $36.62B | 8.38% |
| 2018-06-30 | $3.01B | $35.61B | 8.19% |
| 2018-03-31 | $6.67B | $38.68B | 18.35% |
| 2017-12-31 | $6.62B | $37.70B | 18.85% |
| 2017-09-30 | $5.04B | $34.87B | 14.44% |
| 2017-06-30 | $5.30B | $34.15B | 15.05% |
| 2017-03-31 | $5.12B | $33.84B | 14.49% |
| 2016-12-31 | $5.32B | $36.83B | 14.81% |
| 2016-09-30 | $5.11B | $35.95B | 14.19% |
| 2016-06-30 | $4.81B | $34.77B | 13.26% |
| 2016-03-31 | $5.16B | $36.03B | 13.99% |
| 2015-12-31 | $5.24B | $37.20B | 14.11% |
| 2015-09-30 | $5.06B | $37.18B | 13.56% |
| 2015-06-30 | $4.76B | $37.13B | 12.68% |
| 2015-03-31 | $4.74B | $37.00B | 12.53% |
| 2014-12-31 | $4.64B | $37.96B | 12.19% |
| 2014-09-30 | $4.59B | $38.11B | 12.04% |
| 2014-06-30 | $4.89B | $38.13B | 12.80% |
| 2014-03-31 | $4.77B | $38.21B | 12.41% |
| 2013-12-31 | $4.59B | $37.94B | 11.96% |
| 2013-09-30 | $4.44B | $38.53B | 11.59% |
| 2013-06-30 | $4.20B | $38.91B | 11.08% |
| 2013-03-31 | $4.04B | $38.21B | 10.73% |
| 2012-12-31 | $3.86B | $37.65B | 10.27% |
| 2012-09-30 | $3.81B | $36.92B | 10.11% |
| 2012-06-30 | $3.68B | $37.91B | 9.70% |
| 2012-03-31 | $3.53B | $38.05B | 9.29% |
| 2011-12-31 | $3.46B | $38.05B | 9.13% |
| 2011-09-30 | $3.42B | $37.49B | 9.05% |
| 2011-06-30 | $3.36B | $38.24B | 8.94% |
| 2011-03-31 | $3.37B | $37.92B | 9.10% |
| 2010-12-31 | $3.43B | $37.70B | 9.40% |
| 2010-09-30 | $3.45B | $36.64B | 9.59% |
| 2010-06-30 | $3.66B | $35.87B | 10.25% |
| 2010-03-31 | $3.73B | $35.69B | 10.41% |
| 2009-12-31 | $3.70B | $35.77B | 10.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $79.455B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |